NCT02975050 (ViVUS) is a clinical trial of Location in Health Volunteer Validation Study, sponsored by Zoll Medical Corporation.

Who is sponsoring NCT02975050?

NCT02975050 is sponsored by Zoll Medical Corporation.

What drugs are being tested in NCT02975050?

Interventions in NCT02975050: Location.

What condition does NCT02975050 study?

NCT02975050 studies Health Volunteer Validation Study.

Is NCT02975050 still recruiting?

NCT02975050 is currently completed. Last updated 7 July 2020.

Last reviewed 2020-07-07 · How we verify

NCT02975050: ViVUS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Vital Signs Validation Study of the μ-Cor System (ViVUS Validation)

Completed Last updated 7 July 2020

What this trial tests

trial testing Location in Health Volunteer Validation Study in 30 participants. Completed in 19 January 2017.

Timeline

28 November 2016

Primary endpoint
19 January 2017

19 January 2017

Quick facts

Lead sponsor	Zoll Medical Corporation
Status	Completed
Study type	OBSERVATIONAL
Enrollment	30
Start date	28 November 2016
Primary completion	19 January 2017
Estimated completion	19 January 2017

Drugs / interventions tested

Location

Conditions studied

Health Volunteer Validation Study — all drugs for Health Volunteer Validation Study →

Sponsor

Zoll Medical Corporation — full company profile →

Who can join

21 and older, any sex, with Health Volunteer Validation Study. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study has the following objective: • To validate the capability of the μ-Cor System to monitor ECG, Heart Rate (HR), Respiration Rate (RR), Posture and Activity in healthy human subjects. The μ-Cor validation will be demonstrated at two body locations: 1. Side location (below left armpit) for study arm 1, and 2. Front location (upper left chest) for study arm 2 An FDA-cleared comparator device will be used to support the validation of the study device.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Invasive and Non-Invasive Remote Patient Monitoring Devices for Heart Failure: A Comparative Review of Technical Maturity and Clinical Readiness.
Luque I, Gadea M, Comas A, Becerra-Fajardo L, et al · · 2025 · cited 1× · PMID 41157505 · DOI 10.3390/s25206453

Verify or expand the search:

Other Zoll Medical Corporation trials

Trials by the same sponsor.

NCT06313840 — Central Sleep Apnea Prevalence and Impact on Cognitive Function in Patients With Heart Failure With Reduced or Mildly Re · completed
NCT05505136 — Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in PatientS Wearing a Novel Device With Biometric Based · completed
NCT05604430 — Pre-hospital Ventilation Clinical Study · enrolling by invitation
NCT05073354 — Rapid Treatment of Shock Without Trauma · completed
NCT05013333 — AED 3 Post-Approval Study · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02975050 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zoll Medical Corporation
Last refreshed: 7 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02975050.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing